Role of NAD(P)H oxidase and its regulation in chronic hypertension

Hypertension Research

Volumn 29, Issue 10, 2006, Pages 743-744

  Iwai, Masaru ^a   Mogi, Masaki ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hypertension; NAD(P)H oxidase; Oxidative stress; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE PLUS HYDROCHLOROTHIAZIDE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LIPID PEROXIDE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RENIN; SUPEROXIDE;

BLOOD PRESSURE REGULATION; BRAIN DISEASE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; EDITORIAL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBUNIT; ESSENTIAL HYPERTENSION; HEART VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DISEASE; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; CHRONIC DISEASE; HUMANS; HYPERTENSION; NADPH OXIDASE; OXIDATIVE STRESS;

EID: 33751572289     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.743     Document Type: Editorial

References (15)

1. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR: Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med 2006; 6: 501-514.
2. Tagami M, Yamagata K, Ikeda K, et al: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23-29.
3. Yoshii T, Iwai M, Li Z, et al: Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006; 29: 457-466.
4. Cheng ZJ, Vapaatalo H, Mervaala E: Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11: RA194-RA205.
5. Johar S, Cave AC, Narayanaparticker A, Grieve DJ, Shah AM: Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006; 20: 1546-1548.
6. Zhao W, Swanson SA, Ye J, et al: Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension. Hypertension 2006; 48: 637-643.
7. Iwai M, Chen R, Li Z, et al: Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005; 112: 1636-1643.
8. Inomata H, Watanabe T, Iizuka Y, et al: Identification of quantitative trait loci for cardiac hypertrophy in two different strains of the spontaneously hypertensive rat. Hypertens Res 2005; 28: 273-281.
9. Tagami M, Yamagata K, Ikeda K, et al: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23-29.
10. Goto M, Mukoyama M, Sugawara A, et al: Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens Res 2002; 25: 125-133.
11. Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303-312.
12. Mollnau H, Wendt M, Szocs K, et al: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: E58-E65.
13. Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061.
14. Akasaki T, Ohya Y, Kuroda J, et al: Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens Res 2006; 29: 813-820
15. Shiuchi T, Iwai M, Li HS, et al: Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 2004; 43: 1003-1010.